Zhu-zhu Wang

1 Introduction Lung cancer remains the leading global oncologic challenge, with GLOBOCAN 2022 reporting 2.48 million new cases and 1.82 million annual deaths worldwide, where non-small cell lung cancer (NSCLC) accounts for 85% of diagnoses [1]. Beyond its direct and devastating impact on survival, NSCLC and its associated treatments significantly disrupt body composition (BC), notably accelerating skeletal muscle loss and dysfunction—a condition termed sarcopenia [2, 3].

Keywords Lung neoplasms Cognition Associated factors Cancer-related cognitive impairment Cancer treatments Get full text access Log in, subscribe or purchase for full access. References 1. Bray, F. ∙ Laversanne, M. ∙ Sung, H. ... Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin. 2024; 74:229-263 2. Cao, W. ∙ Chen, H.-D. ∙ Yu, Y.-W. ...